1. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92:827–39.
2. Cawston T, Carrere S, Catterall J, et al. Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. No-vartis Found Symp. 2001; 234:205–18.
Article
3. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69:562–73.
Article
4. Fillmore HL, VanMeter TE, Broaddus WC. Membrane-type matrix metalloproteinases (MTMMPs): expression and function during glioma invasion. J Neurooncol. 2001; 53:187–202.
5. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 2001; 13:534–40.
6. Vo NV, Hartman RA, Yurube T, et al. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J. 2013; 13:331–41.
7. Weiler C, Nerlich AG, Zipperer J, et al. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J. 2002; 11:308–20.
Article
8. Gruber HE, Ingram JA, Hanley EN Jr. Immunolocalization of MMP-19 in the human intervertebral disc: implications for disc aging and degeneration. Biotech Histochem. 2005; 80:157–62.
Article
9. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004; 204:47–54.
Article
10. Richardson SM, Doyle P, Minogue BM, et al. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther. 2009; 11:R126.
Article
11. Roberts S, Caterson B, Menage J, et al. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976). 2000; 25:3005–13.
12. Bachmeier BE, Nerlich A, Mittermaier N, et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J. 2009; 18:1573–86.
Article
13. Crean JK, Roberts S, Jaffray DC, et al. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine (Phila Pa 1976). 1997; 22:2877–84.
Article
14. Le Maitre CL, Freemont AJ, Hoyland JA. Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem. 2006; 81:125–31.
Article
15. Tsarouhas A, Soufla G, Katonis P, et al. Transcript levels of major MMPs and ADAMTS-4 in relation to the clinico-pathological profile of patients with lumbar disc herniation. Eur Spine J. 2011; 20:781–90.
Article
16. Genevay S, Finckh A, Mezin F, et al. Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res Ther. 2009; 11:R169.
Article
17. Haro H, Komori H, Kato T, et al. Experimental studies on the effects of recombinant human matrix metalloproteinases on herniated disc tissues–how to facilitate the natural resorption process of herniated discs. J Orthop Res. 2005; 23:412–9.
Article
18. Kato T, Haro H, Komori H, et al. Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc. J Orthop Res. 2004; 22:895–900.
Article